BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 5474598)

  • 1. [The value of lipavlon in diabetic retinopathy].
    François P; Belervacque A; Turut P
    Bull Soc Ophtalmol Fr; 1970 Apr; 70(4):568-73. PubMed ID: 5474598
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical, biochemical and pathological studies of long term "clofibrate" therapy.
    el-Mehairy MM; Attia O; Nabih AE; Nassar I; Ibrahim WN
    J Trop Med Hyg; 1970 Jul; 73(7):177-81. PubMed ID: 5470220
    [No Abstract]   [Full Text] [Related]  

  • 3. Diabetic retinopathy.
    Harrold BP
    Lancet; 1971 Jan; 1(7688):42. PubMed ID: 4099348
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical trial of C.P.I.B. (clofibrate) in treatment of diabetic hypertriglyceridemia].
    Warembourg H; Jaillard J
    Lille Med; 1968 Jan; 13(1):Suppl:5-8. PubMed ID: 5745605
    [No Abstract]   [Full Text] [Related]  

  • 5. A double-blind controlled trial of clofibrate in the treatment of diabetic retinopathy.
    Harrold BP; Marmion VJ; Gough KR
    Diabetes; 1969 May; 18(5):285-91. PubMed ID: 4894161
    [No Abstract]   [Full Text] [Related]  

  • 6. Serum lipids in an ambulary diabetic clientele. Effect of therapy with Atromidin (clofibrate).
    Bergqvist N
    Acta Med Scand; 1970 Mar; 187(3):213-8. PubMed ID: 5444978
    [No Abstract]   [Full Text] [Related]  

  • 7. Clofibrate and dextrothyroxine in coronary heart diseases. A clinical and biochemical study.
    Bhatia ML; Setty KR; Roy SB
    J Assoc Physicians India; 1971 Feb; 19(2):123-9. PubMed ID: 4934418
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical study of the effect of ethyl-alpha-p-chlorophenoxybutyrate (clofibrate) in the venous retinal thrombosis].
    Cioli S; Nizzola GM
    Ann Ottalmol Clin Ocul; 1970 Sep; 96(9):477-82. PubMed ID: 5519038
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical experience with an antilipemic agent, ethylchlorophenoxyisobutyrate].
    Noleto PA; de Bulhões F; Tuma M
    Rev Bras Med; 1969 Oct; 26(10):602-5. PubMed ID: 5404870
    [No Abstract]   [Full Text] [Related]  

  • 10. [Serum-lipid reducing principles--possibilities for treatment. 6. Indications for the use of clofibrate].
    Gustafson A
    Lakartidningen; 1970 Dec; 67():Suppl IV:75+. PubMed ID: 5511954
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of diabetes insipidus with clofibrate].
    Annee Endocrinol; 1971; 23():101-3. PubMed ID: 5562226
    [No Abstract]   [Full Text] [Related]  

  • 12. Platelet function and platelet phospholipids in patients with hyperbetalipoproteinemia. Effect of nicotinic acid and clofibrate.
    Nordoy A; Rodset JM
    Acta Med Scand; 1971 May; 189(5):385-9. PubMed ID: 5578488
    [No Abstract]   [Full Text] [Related]  

  • 13. [The treatment of exudative diabetic retinopathies with clofibrate (Atromid-S)].
    Houtsmuller AJ
    Ned Tijdschr Geneeskd; 1967 Nov; 111(45):2039-40. PubMed ID: 4863523
    [No Abstract]   [Full Text] [Related]  

  • 14. [Therapeutic study of clofibrate during pituitrin-sensitive diabetes insipidus in children].
    de Gennes JL; Desbois JC; Marie J
    Ann Pediatr (Paris); 1970 Nov; 17(11):754-9. PubMed ID: 5484620
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effect of parachlorophenoxyisobutyric acid (CPIB acid) and of diet on blood cholesterol and on the beta-alpha lipoprotein ratio in aged subjects].
    Bronzini A; Di Gregorio D; Scotti G
    G Gerontol; 1969 Nov; 17(11):1067-75. PubMed ID: 5397791
    [No Abstract]   [Full Text] [Related]  

  • 16. A controlled trial of Atromid therapy in exudative diabetic retinopathy.
    Cullen JF; Ireland JT; Oliver MF
    Trans Ophthalmol Soc U K (1962); 1964; 84():281-95. PubMed ID: 5227423
    [No Abstract]   [Full Text] [Related]  

  • 17. [Treatment of arteriosclerosis by Atromid].
    Ayad H
    Rev Med Moyen Orient; 1967; 24(6):504-11. PubMed ID: 5264185
    [No Abstract]   [Full Text] [Related]  

  • 18. [Treatment of essential hyperlipemia with clofibrate].
    Reuter W; Seifert A
    Z Gesamte Inn Med; 1969 Jun; 24(12):184-7. PubMed ID: 5404292
    [No Abstract]   [Full Text] [Related]  

  • 19. [Use of Clofibrate SPOFA in the treatment of diabetic retinopathy].
    Oláh Z
    Cesk Oftalmol; 1971 Sep; 27(5):315-8. PubMed ID: 5110678
    [No Abstract]   [Full Text] [Related]  

  • 20. A comparison of fenofibrate and clofibrate hypolipidemic effects.
    Daubresse JC
    Acta Clin Belg; 1980; 35(4):227-32. PubMed ID: 7015771
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.